Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort

Advances in therapy of metastatic castration-refractory prostate cancer (mCRPC) resulted in more therapeutic options and led to a higher need of predictive/prognostic biomarkers. Systemic inflammatory biomarkers could provide the basis for personalized treatment selection. This study aimed to assess...

Full description

Bibliographic Details

Main Authors:	Neuberger, Manuel (Author) , Goly, Nora (Author) , Skladny, Janina (Author) , Milczynski, Veronica (Author) , Weiß, Christel (Author) , Wessels, Frederik (Author) , Nitschke, Katja (Author) , Grüne, Britta (Author) , Haney, Caelán Max (Author) , Hartung, Friedrich (Author) , Herrmann, Jonas (Author) , Jarczyk, Jonas (Author) , Kowalewski, Karl-Friedrich (Author) , Waldbillig, Frank (Author) , Kriegmair, Maximilian (Author) , Westhoff, Niklas Christian (Author) , Worst, Thomas (Author) , Nuhn, Philipp (Author)
Format:	Article (Journal)
Language:	English
Published:	July 2023
In:	Journal of cancer research and clinical oncology Year: 2023, Volume: 149, Issue: 7, Pages: 3371-3381
ISSN:	1432-1335
DOI:	10.1007/s00432-022-04220-w
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-022-04220-w Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00432-022-04220-w
Author Notes:	Manuel Neuberger, Nora Goly, Janina Skladny, Veronica Milczynski, Christel Weiß, Frederik Wessels, Katja Nitschke, Britta Grüne, Caelán M. Haney, Friedrich Hartung, Jonas Herrmann, Jonas Jarczyk, Karl F. Kowalewski, Frank Waldbillig, Maximilian C. Kriegmair, Niklas Westhoff, Thomas S. Worst, Philipp Nuhn